Therapeutic monoclonal antibodies are FDA/EMA approved drugs for the treatment of various diseases. The validity, specificity, and reproducibility of these antibodies have been proven in the clinical setting. Therapeutic monoclonal antibodies are now available for research use at 1mg/ml in phosphate buffered saline (PBS) buffer.
Our Products(Reference Drugs as Dilutions) | Antigen | Drug Brand | Volume per Vial | Quantity per vial | |
|---|---|---|---|---|---|
Adalimumab |
TNF alpha |
Humira® |
100 |
0,1 |
|
Bevacizumab |
VEGF-A |
Avastin® |
100 |
0,1 |
|
Cetuximab |
EGFR |
Erbitux® |
100 |
0,1 |
|
Daratumumab |
CD38 |
Darzalex® |
100 |
0,1 |
|
Denosumab |
RANKL |
Prolia® |
100 |
0,1 |
|
Etanercept |
TNF alpha |
Enbrel® |
100 |
0,1 |
|
Golimumab |
TNF alpha |
Simponi® |
100 |
0,1 |
|
Infliximab |
TNF alpha |
Remicade® |
100 |
0,1 |
|
Nivolumab |
PD-1 |
Opdivo® |
100 |
0,1 |
|
Obinutuzumab |
CD20 |
Gazyvaro® |
100 |
0,1 |
|
Palivizumab |
RSV protein F |
Synagis® |
100 |
0,1 |
|
Pembrolizumab |
PD-1 |
Keytruda® |
100 |
0,1 |
|
Ramucirumab |
VEGFR2 |
Cyramza® |
100 |
0,1 |
|
Rituximab |
CD20 |
MabThera® |
100 |
0,1 |
|
Secukinumab |
IL-17 |
Cosentyx® |
100 |
0,1 |
|
Tocilizumab |
IL-6 receptor |
RoActemra® |
100 |
0,1 |
|
Trastuzumab |
HER2 |
Herceptin® |
100 |
0,1 |
|
Ustekinumab |
IL-12 |
Stelara® |
100 |
0,1 |
We generate therapeutic antibody dilutions (1 mg/ml) by diluting original licensed antibody drugs with phosphate-buffered saline (PBS) pH 7.4 as diluent. The samples contain no preservatives (NaN3) and no additional BSA. After dilution, all samples are stored and frozen at -80°C.Â
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin
Let us know about your inquiry details and we’ll contact you shortly.
